2022-08-20 高雄萬豪酒店 10F皇喜會議室 10D-1
時間主題
09:00 ~ 09:10
PD01-1: A genome-wide association study (GWAS) of kidney stone disease in the Taiwanese population.
講者: 李明儒 座長: 周詠欽,
林承家
09:10 ~ 09:20
PD01-2: The sodium-glucose cotransporter-2 inhibitor dapagliflozin inhibit kidney stone formation through modulating AMPK-mediated autophagy
講者: 劉展榮 座長: 周詠欽,
林承家
09:20 ~ 09:30
PD01-3: Urine NT-probnp as a non-invasive indicator for recovery of renal function after receiving ureteroscopic surgery aiming at relieving hydronephrosis
講者: 劉佳旻 座長: 周詠欽,
林承家
09:30 ~ 09:40
PD01-4: Comparison of surgical outcomes between ultramini-endoscopic combined intrarenal surgery and retrograde intrarenal surgery
講者: 潘思穎 座長: 周詠欽,
林承家
09:40 ~ 09:50
PD01-5: Comparative analysis of simultaneous supine percutaneous nephrolithotomy with ureteroscopic lithotripsy and retrograde intrarenal surgery in the management of large proximal ureteral calculi
講者: 林崇裕 座長: 周詠欽,
林承家
09:50 ~ 10:00
PD01-6: Comparison of mini endoscopic combined intrarenal surgery and multitract percutaneous nephrolithotomy specifically for kidney staghorn stones: A single-center experience
講者: 陳致豪 座長: 周詠欽,
林承家